Stock Price, News, Quote and Profile of BIONDVAX PHARMACEUTICALS-ADR(NASDAQ:BVXV) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

BIONDVAX PHARMACEUTICALS-ADR

NASDAQ:BVXV (9/6/2023, 7:00:01 PM)

After market: 1.38 +0.02 (+1.47%)

1.36

+0.05 (+3.82%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryPharmaceuticals

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap4.97M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. BiondVax Pharmaceuticals Ltd core focus is to develop of NanoAbs for treatment of COVID-19, psoriasis and asthma. Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally the Company offers manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for other research and development companies. BiondVax Pharmaceuticals Ltd operates in Israel.

Company Info

BIONDVAX PHARMACEUTICALS-ADR

Jerusalem Biopark, 2Nd Floor, Hadassah Ein Kerem Campus

JERUSALEM 74036

P: 97289302529.0

CEO: Amir Reichman

Employees: 33

Website: https://www.biondvax.com/

BVXV News

8 months ago - BiondVax Pharmaceuticals Ltd.BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics

Scinai Immunotherapeutics to debut tomorrow under Nasdaq ticker symbol “SCNI”

Scinai Immunotherapeutics to debut tomorrow under Nasdaq ticker symbol “SCNI” ...

9 months ago - BiondVax Pharmaceuticals Ltd.BiondVax Reports Second Quarter Financial Results and Provides Business Update

JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- via IBN - BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing,...

9 months ago - Seeking AlphaNasdaq grants BiondVax extension to regain compliance with listing rules (NASDAQ:BVXV)

BiondVax Pharmaceuticals (BVXV) said Nasdaq provided an extension until October end as it reviewed the biotechnology company's multi-faceted plan to regain compliance with Nasdaq’s...

9 months ago - BiondVax Pharmaceuticals Ltd.Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules

BIONDVAX PHARMACEUTICALS-ADR (BVXV)

Nasdaq Stock Screener

USA Stock Screener